Allogeneic Transplantation for Relapsed Waldenström Macroglobulinemia and Lymphoplasmacytic Lymphoma
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 01, 2017
- Source ID
- 10.1016/j.bbmt.2016.10.010
Entities
People
- A. Samer Al-homsi
- Anita D'Souza
- Ayman Saad
- César O. Freytes
- David H. Vesole
- David I. Marks
- Edward Copelan
- Gerhard C Hildebrandt
- Hillard M Lazarus
- Jean Yared
- Jiaxing Huang
- Kwang Woo-ahn
- Mehdi Hamadani
- Michael J Martens
- Miguel-angel Diaz
- Mohamed A Kharfan-Dabaja
- Parameswaran Hari
- Rammurti T. Kamble
- Richard F. Olsson
- Robert F. Cornell
- Robert Peter Gale
- Saad Usmani
- Saurabh Chhabra
- Siddhartha Ganguly
- Taiga Nishihori
- Tamila Kindwall-keller
- Tomer Mark
- Veronika Bachanova
- Yago Nieto
Organizations
- ARIAD Pharmaceuticals
- Actinium Pharmaceuticals (United States)
- Amgen
- Blue Cross Blue Shield Association
- Celgene
- Elevance Health, Inc.
- Fred Hutchinson Cancer Center
- GSK
- Genzyme
- Health Resources and Services Administration
- Incyte
- Kiadis Pharma (Netherlands)
- Leukemia & Lymphoma Society
- Medical College of Wisconsin
- Merck & Co.
- National Cancer Institute
- National Marrow Donor Program
- Office of Naval Research
- Onyx Pharmaceuticals
- Osiris Therapeutics
- Otsuka (United States)
- Roche (United States)
- Sanofi-Aventis
- Seagen
- Sigma-Tau Pharmaceuticals (United States)
- St. Baldrick's Foundation
- StemCyte
- Swedish Orphan Biovitrum
- Takeda Oncology
- Tarix Orphan (United States)
- University of Minnesota
- University of Utah